These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 9293448

  • 1. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 2. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE.
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [Abstract] [Full Text] [Related]

  • 3. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
    Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, Stewart FM, Quesenberry PJ.
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350
    [Abstract] [Full Text] [Related]

  • 4. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ, Shpall EJ, McNiece I, Keller G.
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [Abstract] [Full Text] [Related]

  • 5. In vivo engraftment potential of clinical hematopoietic grafts.
    Leung W, Ramírez M, Novelli EM, Civin CI.
    J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093
    [Abstract] [Full Text] [Related]

  • 6. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
    Monaco G, Konopleva M, Munsell M, Leysath C, Wang RY, Jackson CE, Korbling M, Estey E, Belmont J, Andreeff M.
    Stem Cells; 2004 Aug; 22(2):188-201. PubMed ID: 14990858
    [Abstract] [Full Text] [Related]

  • 7. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G, Baumann M, Meltzer J, Möllers T, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1996 Aug; 208(4):160-7. PubMed ID: 8926682
    [Abstract] [Full Text] [Related]

  • 8. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y, Yoshida S, Saito Y, Doi T, Nagatoshi Y, Fukata M, Saito N, Yang SM, Iwamoto C, Okamura J, Liu KY, Huang XJ, Lu DP, Shultz LD, Harada M, Ishikawa F.
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [Abstract] [Full Text] [Related]

  • 9. Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice.
    Levac K, Menendez P, Bhatia M.
    Exp Hematol; 2005 Nov; 33(11):1417-26. PubMed ID: 16263425
    [Abstract] [Full Text] [Related]

  • 10. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
    Noort WA, Wilpshaar J, Hertogh CD, Rad M, Lurvink EG, van Luxemburg-Heijs SA, Zwinderman K, Verwey RA, Willemze R, Falkenburg JH.
    Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
    [Abstract] [Full Text] [Related]

  • 11. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow-derived human hematopoietic stem cells engraft NOD/SCID mice and traffic appropriately to an inflammatory stimulus in the joint.
    Chang NH, Inman RD, Dick JE, Wither JE.
    J Rheumatol; 2010 Mar; 37(3):496-502. PubMed ID: 20110518
    [Abstract] [Full Text] [Related]

  • 13. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE.
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [Abstract] [Full Text] [Related]

  • 14. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
    Wilpshaar J, Noort WA, Kanhai HH, Willemze R, Falkenburg JH.
    Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
    [Abstract] [Full Text] [Related]

  • 15. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
    Ramírez M, Díaz MA, Madero L, Bueren JA.
    Leuk Res; 2003 Dec; 27(12):1153-7. PubMed ID: 12921954
    [Abstract] [Full Text] [Related]

  • 16. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.
    Stem Cells; 1999 Dec; 17(3):152-61. PubMed ID: 10342558
    [Abstract] [Full Text] [Related]

  • 17. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y, Sun A, Han ZC.
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [Abstract] [Full Text] [Related]

  • 18. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO, Danet-Desnoyers GA, Zhang Y, Frank DM, Riley JL, Levine BL, Porter DL, June CH, Emerson SG.
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [Abstract] [Full Text] [Related]

  • 19. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 Oct; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 20. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.